IN2014CN02765A - - Google Patents

Info

Publication number
IN2014CN02765A
IN2014CN02765A IN2765CHN2014A IN2014CN02765A IN 2014CN02765 A IN2014CN02765 A IN 2014CN02765A IN 2765CHN2014 A IN2765CHN2014 A IN 2765CHN2014A IN 2014CN02765 A IN2014CN02765 A IN 2014CN02765A
Authority
IN
India
Prior art keywords
medicament
sodium salt
montelukast sodium
photodegradation
formulating
Prior art date
Application number
Other languages
English (en)
Inventor
In Sang Lee
Seok Ju Lee
Hyunik Shin
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of IN2014CN02765A publication Critical patent/IN2014CN02765A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
IN2765CHN2014 2011-10-17 2012-10-16 IN2014CN02765A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110106064A KR20130041664A (ko) 2011-10-17 2011-10-17 고순도 몬테루카스트 나트륨 염의 제조 방법
PCT/KR2012/008411 WO2013058511A2 (ko) 2011-10-17 2012-10-16 고순도 몬테루카스트 나트륨 염의 제조 방법

Publications (1)

Publication Number Publication Date
IN2014CN02765A true IN2014CN02765A (ko) 2015-07-03

Family

ID=48141519

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2765CHN2014 IN2014CN02765A (ko) 2011-10-17 2012-10-16

Country Status (5)

Country Link
JP (1) JP2014530234A (ko)
KR (1) KR20130041664A (ko)
CN (1) CN103889957A (ko)
IN (1) IN2014CN02765A (ko)
WO (1) WO2013058511A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016020321A (ja) * 2014-07-16 2016-02-04 大日本印刷株式会社 モンテルカストまたはその塩の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007096889A2 (en) * 2006-02-27 2007-08-30 Chemagis Ltd. Process for preparing montelukast and salts thereof
US7700776B2 (en) * 2006-10-24 2010-04-20 Formosa Laboratories, Inc. Compounds and preparation for montelukast sodium
US8115004B2 (en) * 2006-11-20 2012-02-14 Msn Laboratories Limited Process for pure montelukast sodium through pure intermediates as well as amine salts
PL205444B1 (pl) * 2007-05-02 2010-04-30 Zak & Lstrok Ady Farmaceutyczn Sposób wytwarzania soli sodowej kwasu 1-(((1(R)-(3-(2-(7--chloro-2- chinolinylo)-etenylo)fenylo)-3-(2-(1-hydroksy-1- metyloetylo)fenylo)propylo)sulfanylo)metylo)-cyklopropanooctowego
CN101323589B (zh) * 2008-03-06 2010-10-06 台耀化学股份有限公司 化合物及孟鲁司特钠的制备方法
EP2265586A4 (en) * 2008-03-17 2012-10-03 Reddys Lab Ltd Dr PREPARATION OF MONTELUKAST AND ITS SALTS
KR101123292B1 (ko) * 2008-09-26 2012-03-19 주식회사 엘지생명과학 몬테루카스트 나트륨염의 제조방법
KR100990046B1 (ko) * 2010-07-30 2010-10-26 동국제약 주식회사 신규한 몬테루카스트 4-할로 벤질아민염 및 이를 이용한 몬테루카스트 나트륨염의 제조방법

Also Published As

Publication number Publication date
WO2013058511A3 (ko) 2013-06-13
KR20130041664A (ko) 2013-04-25
JP2014530234A (ja) 2014-11-17
CN103889957A (zh) 2014-06-25
WO2013058511A2 (ko) 2013-04-25

Similar Documents

Publication Publication Date Title
TN2014000058A1 (en) A Novel 1,2,3,4-Tetrahydroquinoline Derivative Useful for the Treatment of Diabetes
GEP20207160B (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
TN2015000281A1 (fr) Lactames condenses aryliques et heteroaryliques
PH12016502378A1 (en) Substituted dihydroisoquinolinone compounds
IN2014MN02106A (ko)
UY34917A (es) Inhibidores de la producción de leucotrieno-a4-hidrolasa (lta4h), composiciones farmacéuticas que los contienen y proceso para su preparación
EA201301019A1 (ru) Бензодиоксановые ингибиторы продуцирования лейкотриена
GEP201706690B (en) Novel process for making compounds for use in treatment of cancer
EA201690386A1 (ru) Соединения и композиции в качестве ингибиторов mek
PH12014501711A1 (en) Benzyl sulfonamide derivatives useful as mogat-2 inhibitors
MX343377B (es) Carboxamidas azaheterocilcicas de amina ciclica.
PH12014501712A1 (en) Novel morpholinyl derivatives useful as mogat-2-inhibitors
MY160902A (en) Process for the preparation of the L-arginine salt of perindopril
MX2013008699A (es) Compuestos para reducir la produccion de beta-amiloide.
MD20160111A2 (ro) Derivaţi diheterociclici legaţi de cicloalchil
EA201001362A1 (ru) Хинолины в качестве ингибиторов фарнезилпирофосфатсинтазы
IN2014CN02765A (ko)
MX2018015269A (es) Derivados de tailanstatina a, metodos de tratamiento y metodos de sintesis de los mismos.
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
MA39756B1 (fr) Nouveau sel de l'ivabradine et son procédé de préparation
TN2014000307A1 (en) Novel morpholinyl derivatives useful as mogat-2 inhibitors
TN2014000308A1 (en) Benzyl sulfonamide derivatives useful as mogat - 2 inhibitors
GB2527958A (en) Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents
IN2013CH03943A (ko)
MY151084A (en) Method for preparing 2-imidazolones